Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - dovepress.com
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
C Melguizo, L Cabeza, J Prados… - Drug design …, 2015 - pubmed.ncbi.nlm.nih.gov
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - go.gale.com
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - search.proquest.com
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
[HTML][HTML] Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - ncbi.nlm.nih.gov
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles.
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - europepmc.org
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles.
C Melguizo, L Cabeza, J Prados, R Ortiz… - Drug Design …, 2015 - europepmc.org
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …